日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Fcγ Receptor Polymorphism in Patients with Relapsed/Refractory High-Risk Neuroblastoma Correlates with Outcomes in the SIOPEN Dinutuximab Beta Long-Term Infusion Trial

复发/难治性高危神经母细胞瘤患者的Fcγ受体多态性与SIOPEN Dinutuximab Beta长期输注试验的预后相关

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-25-0180
Lode, Holger N; Siebert, Nikolai; Valteau-Couanet, Dominique; Garaventa, Alberto; Canete, Adela; Anderson, John; Yaniv, Isaac; Ash, Shifra; Gray, Juliet; Klingebiel, Thomas; Loibner, Hans; Luksch, Roberto; Manzitti, Carla; Michon, Jean Marie; Owens, Cormac; Pötschger, Ulrike; Troschke-Meurer, Sascha; Glogova, Evgenia; Ladenstein, Ruth
信号转导
细胞生物学
发表日期：2025
文献求助 收藏

Dinutuximab Beta Versus Naxitamab in the Treatment of Relapsed/Refractory Neuroblastoma in Patients with Stable Disease, Minor Response or Partial Response and Disease in Bone or Bone Marrow: Systematic Review and Matching-Adjusted Indirect Comparison

迪努妥昔单抗β与纳西他单抗治疗复发/难治性神经母细胞瘤患者的疗效比较：系统评价和匹配调整间接比较，这些患者病情稳定、轻微缓解或部分缓解，且伴有骨或骨髓转移。

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17172723
Lode, Holger N; Holko, Przemysław; Wieczorek, Aleksandra; Siebert, Nikolai; Valteau-Couanet, Dominique; Garaventa, Alberto; Cañete, Adela; Anderson, John; Yaniv, Isaac; Ash, Shifra; Gray, Juliet; Luksch, Roberto; Manzitti, Carla; Troschke-Meurer, Sascha; Ebeling, Torsten; Kawalec, Paweł; Śladowska, Katarzyna; Ladenstein, Ruth L
细胞生物学
发表日期：2025
文献求助 收藏

Affinity Affects the Functional Potency of Anti-GD2 Antibodies by Target-Mediated Drug Disposition.

亲和力通过靶向介导的药物处置影响抗GD2抗体的功能效力

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17152510
Troschke-Meurer Sascha, Zumpe Maxi, Ahrenberg Peter Moritz, Ebeling Torsten, Siebert Nikolai, Grabarczyk Piotr, Lode Holger N
免疫/内分泌
发表日期：2025
文献求助 收藏

Dinutuximab beta versus historical controls in the treatment of relapsed neuroblastoma: unadjusted and adjusted indirect comparisons

Dinutuximab beta 与历史对照组在复发性神经母细胞瘤治疗中的比较：未调整和调整后的间接比较

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2025.1736165
Lode, Holger N; Holko, Przemysław; Wieczorek, Aleksandra; Śladowska, Katarzyna; Siebert, Nikolai; Valteau-Couanet, Dominique; Garaventa, Alberto; Cañete, Adela; Anderson, John; Yaniv, Isaac; Ash, Shifra; Moreno, Lucas; Gray, Juliet; Luksch, Roberto; Laureys, Genevieve; Owens, Cormac; Manzitti, Carla; Troschke-Meurer, Sascha; Kawalec, Paweł; Ladenstein, Ruth L
细胞生物学
发表日期：2025
文献求助 收藏

Effect and Tolerance of N5 and N6 Chemotherapy Cycles in Combination with Dinutuximab Beta in Relapsed High-Risk Neuroblastoma Patients Who Failed at Least One Second-Line Therapy

N5和N6化疗周期联合Dinutuximab Beta治疗复发性高危神经母细胞瘤患者（至少接受过一种二线治疗）的疗效和耐受性

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers15133364
Lode, Holger N; Ladenstein, Ruth; Troschke-Meurer, Sascha; Struppe, Linda; Siebert, Nikolai; Zumpe, Maxi; Ehlert, Karoline; Huber, Stefanie; Glogova, Evgenia; Hundsdoerfer, Patrick; Eggert, Angelika; Zaniewska-Tekieli, Anna; Balwierz, Walentyna; Wieczorek, Aleksandra
细胞生物学
发表日期：2023
文献求助 收藏

GMP-Compliant Manufacturing of TRUCKs: CAR T Cells targeting GD(2) and Releasing Inducible IL-18

符合GMP规范的TRUCKs生产：靶向GD(2)并释放诱导型IL-18的CAR T细胞

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2022.839783
Glienke, Wolfgang; Dragon, Anna Christina; Zimmermann, Katharina; Martyniszyn-Eiben, Alexandra; Mertens, Mira; Abken, Hinrich; Rossig, Claudia; Altvater, Bianca; Aleksandrova, Krasimira; Arseniev, Lubomir; Kloth, Christina; Stamopoulou, Andriana; Moritz, Thomas; Lode, Holger N; Siebert, Nikolai; Blasczyk, Rainer; Goudeva, Lilia; Schambach, Axel; Köhl, Ulrike; Eiz-Vesper, Britta; Esser, Ruth
T细胞
T细胞
细胞生物学
IL-18
免疫/内分泌
发表日期：2022
文献求助 收藏

Immunophenotyping of Circulating and Intratumoral Myeloid and T Cells in Glioblastoma Patients

胶质母细胞瘤患者循环和肿瘤内髓系细胞及T细胞的免疫表型分析

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers14235751
Marx, Sascha; Wilken, Fabian; Miebach, Lea; Ispirjan, Mikael; Kinnen, Frederik; Paul, Sebastian; Bien-Möller, Sandra; Freund, Eric; Baldauf, Jörg; Fleck, Steffen; Siebert, Nikolai; Lode, Holger; Stahl, Andreas; Rauch, Bernhard H; Singer, Stephan; Ritter, Christoph; Schroeder, Henry W S; Bekeschus, Sander
肿瘤
T细胞
肿瘤免疫
T细胞
细胞生物学
免疫/内分泌
发表日期：2022
文献求助 收藏

The Immunocytokine FAP-IL-2v Enhances Anti-Neuroblastoma Efficacy of the Anti-GD(2) Antibody Dinutuximab Beta.

免疫细胞因子 FAP-IL-2v 增强抗 GD(2) 抗体 Dinutuximab Beta 的抗神经母细胞瘤疗效

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers14194842
Siebert Nikolai, Leopold Justus, Zumpe Maxi, Troschke-Meurer Sascha, Biskupski Simon, Zikoridse Alexander, Lode Holger N
神经科学
细胞生物学
发表日期：2022
文献求助 收藏

First-line Anti-GD2 Therapy Combined With Consolidation Chemotherapy in 3 Patients With Newly Diagnosed Metastatic Ewing Sarcoma or Ewing-like Sarcoma

一线抗GD2疗法联合巩固化疗治疗3例新诊断的转移性尤文氏肉瘤或尤文氏样肉瘤患者

期刊:Journal of Pediatric Hematology Oncology
影响因子:0.8
doi:10.1097/MPH.0000000000002488
Spasov, Neofit J; Dombrowski, Frank; Lode, Holger N; Spasova, Mariya; Ivanova, Liliya; Mumdjiev, Ivan; Burnusuzov, Hassan; Siebert, Nikolai
发表日期：2022
文献求助 收藏

Nivolumab and dinutuximab beta in two patients with refractory neuroblastoma

纳武利尤单抗和迪努妥昔单抗β治疗两例难治性神经母细胞瘤患者

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2020-000540
Ehlert, Karoline; Hansjuergens, Ina; Zinke, Andreas; Otto, Sylke; Siebert, Nikolai; Henze, Guenter; Lode, Holger
细胞生物学
发表日期：2020
文献求助 收藏